全科医生主导的简短叙事暴露干预对重症监护后创伤后应激障碍症状的影响(PICTURE):多中心、观察者盲法、随机对照试验
PICTURE多中心观察者盲法随机对照试验在德国319家全科诊所纳入319例重症监护后伴PTSD症状的成人(18-85岁),随机分为干预组(n=160,3次全科医生叙事暴露咨询+8次护士预约联系)和强化常规治疗组(n=159,基于德国PTSD指南)。主要终点为6个月时PDS-5自评PTSD症状(0-80分,分高症状重),最小临床重要差异为6分。6个月时组间PDS-5评分平均差异4.7分(95%CI 1.6-7.8,P=0.003,Cohen's d=0.37),12个月时5.4分(95%CI 1.8-9.0,P=0.003,Cohen's d=0.41),均低于预设最小临床重要差异;干预组在抑郁、健康相关生活质量和残疾方面改善更大。作者认为该干预可行且症状有减轻,支持在初级保健中进一步评估。
要点
- 重症后伴PTSD症状成人中,全科医生主导简短叙事暴露干预6个月PDS-5评分较强化常规治疗平均降低4.7分(95%CI 1.6-7.8,P=0.003),未达预设6分最小临床重要差异。
- 12个月随访时组间PDS-5评分差异为5.4分(95%CI 1.8-9.0,P=0.003,Cohen's d=0.41),同样低于6分最小临床重要差异。
- 干预组在抑郁、健康相关生活质量和残疾等次要结局上改善大于强化常规治疗组。
- 干预方案为3次全科医生叙事暴露咨询加8次护士预约联系,对照组接受基于德国PTSD指南的强化常规治疗。
- 作者结论认为该干预可行且显示症状减轻,支持在初级保健中进一步评估该干预。
适用人群与场景
- 18-85岁重症监护后存活且伴PTSD症状的成人,从ICU出院后随机分组。
- 研究在德国319家全科诊所的初级保健场景中进行。
诊断标准与关键阈值
- 主要临床结局采用DSM-5创伤后诊断量表(PDS-5)自评PTSD症状,评分范围0-80分,分数越高症状越严重。
- 最小临床重要差异预设为6分。
处置流程与药物剂量
- 干预组:接受3次全科医生叙事暴露咨询,并安排8次护士预约联系。
- 对照组:接受基于德国PTSD指南的强化常规治疗。
研究设计与关键结果
- 多中心、观察者盲法、随机对照试验(PICTURE),在德国319家全科诊所纳入319例重症监护后伴PTSD症状成人,干预组n=160,对照组n=159。
- 2018年10月21日至2023年1月18日期间筛查1283例ICU出院患者,随机分配319例;平均年龄57.7岁(SD 12.7),61%为男性;两组基线PDS-5平均分均为30.6(SD 13.3)。
- 6个月随访完成271例(85%),12个月随访完成247例(77%)。
- 主要终点:6个月时PDS-5评分组间平均差异4.7分(95%CI 1.6-7.8,P=0.003,Cohen's d=0.37);12个月时组间平均差异5.4分(95%CI 1.8-9.0,P=0.003,Cohen's d=0.41)。
- 次要结局:干预组在抑郁、健康相关生活质量和残疾方面改善大于对照组。
证据类型、等级与局限
- 证据类型:多中心、观察者盲法、随机对照试验(RCT)。
- 作者结论:在重症后PTSD症状成人中,简短叙事暴露干预可行并显示症状减轻,但减轻幅度低于预设最小临床重要差异;效应在12个月随访时持续;这些发现支持在初级保健中进一步评估该干预。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为该简短叙事暴露干预可行且显示重症后PTSD症状减轻,支持在初级保健中进一步评估该干预。
- 6个月和12个月PDS-5评分改善均低于预设6分最小临床重要差异,原文未据此给出推荐。
指南或共识出处
- PICTURE试验,ClinicalTrials.gov注册号NCT03315390;DRKS-ID DRKS00012589。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine the effect of a novel brief general practitioner (GP)-led narrative exposure intervention on post-traumatic stress disorder (PTSD) symptoms after intensive care.
DESIGN: Multicentre, observer blind, randomised controlled trial (PICTURE).
SETTING: Primary care in 319 general practices across Germany.
PARTICIPANTS: 319 adults (18-85 years) who have survived critical illness with symptoms of PTSD, discharged from intensive care and randomised to receive the intervention (n=160) or improved usual care (n=159) from a general practitioner.
INTERVENTIONS: Intervention group participants had three narrative exposure consultations with a general practitioner and eight scheduled contacts with a nurse. Control group participants received improved treatment as usual based on the German PTSD guideline.
MAIN OUTCOME MEASURES: The primary clinical outcome was self-reported PTSD symptoms using the Post-Traumatic Diagnostic Scale for DSM-5 (PDS-5, range 0-80, higher scores indicating more severe symptoms) at six months. The minimal clinically important difference was six points. Secondary outcomes included changes in depression, anxiety, patient activation, health related quality of life and disability at six and 12 months.
RESULTS: Between 21 October 2018 and 18 January 2023, 1283 patients discharged from an intensive care unit were screened for PTSD symptoms. 319 study participants were randomly assigned either to the control group (n=159) or the intervention group (n=160). The mean patient age was 57.7 years (standard deviation (SD) 12.7), and 61% of participants were male. The mean baseline PDS-5 score was 30.6 (SD 13.3) in both groups. 271 (85%) study participants completed follow-up assessment after six months and 247 (77%) after 12 months. The intervention effect showed a mean between-group difference in the PDS-5 score of 4.7 points ((95% confidence interval 1.6 to 7.8); P=0.003, Cohen's d=0.37)) at six months and 5.4 points ((1.8 to 9.0); P=0.003, Cohen's d=0.41)) at 12 months. Among secondary outcomes, patients in the intervention group had greater improvements in depression, health related quality of life, and disability.
CONCLUSIONS: In adults with symptoms of PTSD after critical illness, a brief narrative exposure intervention was feasible and showed a reduction of symptoms, which was less than the predefined minimal clinically important difference. The effect was found to be sustained at 12 months' follow-up. These findings support the further evaluation of this intervention in primary care.
TRIAL REGISTRATION: ClinicalTrials.gov, NCT03315390; DRKS-ID DRKS00012589.
参考来源
- Gensichen J, Schmidt KFR, Sanftenberg L, et al. Effects of a general practitioner-led brief narrative exposure intervention on symptoms of post-traumatic stress disorder after intensive care (PICTURE): multicentre, observer blind, randomised controlled trial. BMJ. 2025. PMID: 40335079. doi:10.1136/bmj-2024-082092
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。